Andere talen GlycoMimetics, Inc.

Aandelen

GLYC

US38000Q1022

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 18-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,16 ^USD	-5,26%		-13,77%	-8,47%

27/03	Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024
27/03	GlycoMimetics, Inc. rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

GlycoMimetics: Q4 Earnings Snapshot	27/03
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023	27/03
GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
GlycoMimetics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/03
North American Morning Briefing : Stocks Edge -2-	27/03
GlycoMimetics to Report Fourth Quarter and 2023 Full Year Financial Results on March 27, 2024	13/03
GlycoMimetics to Participate in Upcoming Cowen 44th Annual Health Care Conference	26/02
GlycoMimetics Reports Inducement Grant under NASDAQ Listing Rule 5635(4)	13/02
GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	12/02
GlycoMimetics, Inc. Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1A Healthy Volunteer Study of GMI-1687	04/01
GlycoMimetics Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1a Healthy Volunteer Study of GMI-1687	04/01
Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia	03/01
GlycoMimetics, Thermo Fisher Unit Set Accord for Manufacturing Uproleselan for Acute Myeloid Leukemia	02/01
GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia	10/12
GlycoMimetics to Participate in Upcoming Jefferies London Healthcare Conference	09/11
GlycoMimetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03/11
GlycoMimetics: Q3 Earnings Snapshot	03/11
GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2023	03/11
GlycoMimetics to Report Third Quarter 2023 Financial Results on November 3, 2023	23-10-23
GlycoMimetics to Report Third Quarter 2023 Financial Results on November 3, 2023	20-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen GlycoMimetics, Inc.

Aandelen

GLYC

US38000Q1022

Andere talen

Filters